Organ-specific irAEs and the clinical characteristics
Patients, n (%) | Months since therapy initiation, median (range)a | |
---|---|---|
Colitis (total) | 28 (19) | 1.9 (0.4–4.7) |
Sarcoid-like lymphadenopathy | 8b (5) | 3.2 (0.2–9.1) |
Pneumonitis | 8c (5) | 2.3 (1.1 – 8.3) |
Hepatitis | 3 (2) | 1.4 (0.3–2.7) |
Thyroiditis | 2 (1) | 4.3 (4.0–4.7) |
Pancreatitis | 1 (0.6) | 3.8 (3.8) |